Literature DB >> 9543134

A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states.

D A Papanicolaou1, J A Yanovski, G B Cutler, G P Chrousos, L K Nieman.   

Abstract

Cushing's syndrome (CS) may be difficult to distinguish from pseudo-Cushing states (PCS) based on physical findings or urinary glucocorticoid excretion. As the lack of diurnal variation in serum cortisol is characteristic of CS, we studied whether diurnal cortisol determinations could discriminate CS from PCS. Two hundred and sixty-three patients were evaluated: 240 had CS, and 23 had PCS. Urine was collected for 24 h for measurement of cortisol and 17-hydroxycorticosteroids (17OHCS). Blood was drawn at 2300, 2330, 0000, 0030, and 0100 h and at 0600, 0630, 0700, 0730, and 0800 h the next morning for serum cortisol determination. The main outcome measure was the sensitivity of these parameters for the diagnosis of CS at 100% specificity. A midnight cortisol value greater than 7.5 microg/dL correctly identified 225 of 234 patients with CS and all PCS patients. This sensitivity (96%) was superior to that obtained for any other measure, including urinary cortisol (45%), 17OHCS (22%), any other individual cortisol time point (10-92%), the morning (23%) or the evening (93%) cortisol mean, and the ratio (11%) of morning to evening values. We conclude that at 100% specificity, a single serum cortisol value above 7.5 microg/dL at midnight discriminates CS from PCS with higher sensitivity than 24-h urinary cortisol or 17OHCS, or other individual or combined measures of serum cortisol.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543134     DOI: 10.1210/jcem.83.4.4733

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Circadian variation in Cushing's disease and pseudo-Cushing states by analysis of F and ACTH pulsatility.

Authors:  J M Cunningham; O M Buxton; R E Weiss
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

2.  [Circadian rhythms in endocrinology].

Authors:  B Schultes; H L Fehm
Journal:  Internist (Berl)       Date:  2004-09       Impact factor: 0.743

Review 3.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

4.  Carbamazepine and false positive dexamethasone suppression tests for Cushing's syndrome.

Authors:  Ronald C W Ma; Wing Bun Chan; Wing Yee So; Peter C Y Tong; Juliana C N Chan; Chun Chung Chow
Journal:  BMJ       Date:  2005-02-05

Review 5.  Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.

Authors:  S Tsagarakis; D Vassiliadi; N Thalassinos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 6.  Dynamic testing in Cushing's syndrome.

Authors:  Blerina Kola; Ashley B Grossman
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

7.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

Review 8.  Cushing's syndrome: from physiological principles to diagnosis and clinical care.

Authors:  Hershel Raff; Ty Carroll
Journal:  J Physiol       Date:  2015-01-05       Impact factor: 5.182

Review 9.  Cushing's disease.

Authors:  Martina De Martin; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

10.  Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.

Authors:  M E Pall; M C Lao; S S Patel; M L Lee; D E Ghods; D W Chandler; T C Friedman
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.